Back to search
FDAFDA · Food and drugs·Recall number D-0505-2024

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

Published May 29, 2024 · Recall initiated: May 10, 2024

Summary

FDA records drug Class II recall D-0505-2024, published May 29, 2024 and initiated May 10, 2024. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 66 bottles of 30 tablets; Lot: Lot #: J2022G, Exp: 01/01/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
Product distributed to CA, FL, OK, KS and CT
Lot
Lot #: J2022G, Exp: 01/01/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03 recalled?

Yes. FDA published recall D-0505-2024 on May 29, 2024. Reported hazard: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter